Loomis, Sayles & Company’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-54,443
Closed -$563K – 853
2018
Q4
$563K Sell
54,443
-110,377
-67% -$1.63M ﹤0.01% 558
2018
Q3
$2.82M Sell
164,820
-242,190
-60% -$4.16M 0.01% 518
2018
Q2
$7.33M Buy
407,010
+3,206
+0.8% +$64.3K 0.01% 489
2018
Q1
$7.07M Buy
+403,804
New +$8.43M 0.02% 492
2016
Q2
– Sell
-574
Closed -$10K – 1104
2016
Q1
$10K Buy
+574
New +$8.56K ﹤0.01% 828
2015
Q2
– Sell
-5,400
Closed -$101K – 934
2015
Q1
$101K Buy
+5,400
New +$92.6K ﹤0.01% 693

Other funds holding PTEN

Loomis, Sayles & Company's PTEN Position: Q1 2019 in Review

Loomis, Sayles & Company sold out of Patterson-UTI (PTEN) in Q1 2019, closing a stake of 54,443 shares — an estimated $563K sold.

Loomis, Sayles & Company first reported a position in PTEN in Q1 2015 and held it in 6 quarters. The position peaked at $7.33M in Q2 2018. 303 funds tracked by Wall St. Rank hold PTEN as of Q1 2019.

  • Loomis, Sayles & Company reported no remaining Patterson-UTI position as of Q1 2019 after selling out during the quarter.
  • Loomis, Sayles & Company sold 54,443 Patterson-UTI shares in Q1 2019, an estimated $563K.
  • Loomis, Sayles & Company first reported a position in Patterson-UTI in Q1 2015 and held it in 6 quarters.
  • Loomis, Sayles & Company's Patterson-UTI position peaked at $7.33M in Q2 2018.
  • 303 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2019.

Based on Loomis, Sayles & Company's 13F filing for Q1 2019, filed 15 May 2019.